Medtronic, a leading medical technology company, saw its stock price fluctuate in recent months, with institutional investors adjusting their holdings. Dynamic Advisor Solutions LLC reduced its stake by 33.5% in the fourth quarter, while other investors, including Clear Harbor Asset Management LLC, Guardian Wealth Management Inc., and First PREMIER Bank, increased their positions.
Medtronic's recent earnings report revealed strong performance, exceeding analyst expectations. The company reported $1.26 earnings per share for the quarter, surpassing the consensus estimate of $1.25. Revenue also surpassed expectations, reaching $8.40 billion compared to the estimated $8.27 billion.
Analysts remain optimistic about Medtronic's future prospects, with an average rating of "Hold" and an average target price of $95.00. The company's focus on innovative medical technologies and its strong financial performance continue to attract investor interest.